Sivik Global Healthcare’s Biogen BIIB Stock Holding History

Sivik Global Healthcare’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75M	Hold	15,000	–	–	2.09%	26
2026 Q1	$2.75M	Sell	15,000 -5,000	-25%	-$921K	2.09%	26
2025 Q4	$3.52M	Buy	+20,000	New	+$3.27M	1.02%	37
2024 Q3	–	Sell	-30,000	Closed	-$6.96M	–	37
2024 Q2	$6.96M	Buy	30,000 +19,966	+199%	+$4.34M	2.5%	15
2024 Q1	$2.16M	Sell	10,034 -14,966	-60%	-$3.51M	0.51%	46
2023 Q4	$6.47M	Buy	+25,000	New	+$6.14M	2.7%	14
2023 Q3	–	Sell	-10,000	Closed	-$2.85M	–	38
2023 Q2	$2.85M	Hold	10,000	–	–	0.67%	35
2023 Q1	$2.78M	Hold	10,000	–	–	1.2%	37
2022 Q4	$2.77M	Hold	10,000	–	–	1.3%	34
2022 Q3	$2.67M	Buy	+10,000	New	+$2.12M	1.48%	32
2021 Q3	–	Sell	-20,000	Closed	-$6.92M	–	47
2021 Q2	$6.92M	Buy	20,000 +7,500	+60%	+$2.27M	1.35%	21
2021 Q1	$3.5M	Buy	+12,500	New	+$3.37M	1.28%	36
2020 Q4	–	Sell	-12,000	Closed	-$3.4M	–	40
2020 Q3	$3.4M	Sell	12,000 -3,000	-20%	-$837K	1.46%	35
2020 Q2	$4.01M	Sell	15,000 -5,000	-25%	-$1.5M	1.33%	35
2020 Q1	$6.33M	Hold	20,000	–	–	2.5%	20
2019 Q4	$5.93M	Buy	+20,000	New	+$5.55M	2.2%	22
2019 Q2	–	Sell	-15,000	Closed	-$3.55M	–	62
2019 Q1	$3.55M	Sell	15,000 -5,000	-25%	-$1.57M	1.31%	37
2018 Q4	$6.02M	Buy	20,000 +2,500	+14%	+$798K	3.24%	9
2018 Q3	$6.18M	Sell	17,500 -5,000	-22%	-$1.72M	2.21%	19
2018 Q2	$6.53M	Buy	22,500 +7,500	+50%	+$2.11M	2.51%	12
2018 Q1	$4.11M	Sell	15,000 -5,000	-25%	-$1.55M	1.92%	22
2017 Q4	$6.37M	Sell	20,000 -2,500	-11%	-$802K	2.36%	12
2017 Q3	$7.04M	Buy	22,500 +2,500	+13%	+$740K	2.4%	16
2017 Q2	$5.43M	Buy	20,000 +5,000	+33%	+$1.32M	1.99%	19
2017 Q1	$4.1M	Sell	15,000 -5,000	-25%	-$1.41M	1.91%	26
2016 Q4	$5.67M	Hold	20,000	–	–	2.71%	15
2016 Q3	$6.26M	Hold	20,000	–	–	3.16%	11
2016 Q2	$4.84M	Buy	20,000 +5,000	+33%	+$1.32M	2.4%	14
2016 Q1	$3.9M	Buy	15,000 +2,500	+20%	+$660K	1.73%	26
2015 Q4	$3.83M	Sell	12,500 -7,500	-38%	-$2.16M	1.82%	21
2015 Q3	$5.84M	Sell	20,000 -4,800	-19%	-$1.59M	2.83%	8
2015 Q2	$10M	Buy	24,800 +7,300	+42%	+$2.93M	3.48%	5
2015 Q1	$7.39M	Sell	17,500 -5,034	-22%	-$1.98M	2.51%	6
2014 Q4	$7.65M	Buy	22,534 +7,534	+50%	+$2.44M	3.1%	3
2014 Q3	$4.96M	Buy	15,000 +5,000	+50%	+$1.65M	2.26%	11
2014 Q2	$3.15M	Buy	10,000 +3,000	+43%	+$903K	1.59%	26
2014 Q1	$2.14M	Sell	7,000 -3,000	-30%	-$952K	1.34%	35
2013 Q4	$2.8M	Buy	+10,000	New	+$2.59M	1.99%	23

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Sivik Global Healthcare's BIIB Position: Q2 2026 in Review

Sivik Global Healthcare held its Biogen (BIIB) position steady in Q2 2026 at 15,000 shares worth $2.75M. The position accounts for 2.09% of the portfolio, ranked #26.

Sivik Global Healthcare first reported a position in BIIB in Q4 2013 and has held it in 38 quarters since. The position peaked at $10M in Q2 2015. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Sivik Global Healthcare held 15,000 shares of Biogen worth $2.75M as of Q2 2026.
Sivik Global Healthcare left its Biogen share count unchanged in Q2 2026.
Biogen made up 2.09% of Sivik Global Healthcare's portfolio in Q2 2026, its #26 holding.
Sivik Global Healthcare first reported a position in Biogen in Q4 2013 and has held it in 38 quarters since.
Sivik Global Healthcare's Biogen position peaked at $10M in Q2 2015.
269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.